Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Cremer

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|March 19, 2010
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistanceJulien Cherfils-Vicini, Sophia Platonova, Mélanie Gillard, et al.
Oncoimmunology|December 15, 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon, Kristina Iribarren, Florent Petitprez, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene AlterationsAudrey Mansuet-Lupo, Marco Alifano, Nicolas Pécuchet, et al.
Oncoimmunology|February 16, 2017
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancerLaetitia Fend, Sylvie Rusakiewicz, Julien Adam, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Cancer Research|July 31, 2014
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancerSaradiya Chatterjee, Lucile Crozet, Diane Damotte, et al.
Cancer Research|February 5, 2016
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable PrognosisJitka Fucikova, Etienne Becht, Kristina Iribarren, et al.
Plos One|September 20, 2014
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerMarco Alifano, Audrey Mansuet-Lupo, Filippo Lococo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophilsYoan Velut, Elise Decroix, Hélène Blons, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|March 19, 2010
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistanceJulien Cherfils-Vicini, Sophia Platonova, Mélanie Gillard, et al.
Oncoimmunology|December 15, 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon, Kristina Iribarren, Florent Petitprez, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene AlterationsAudrey Mansuet-Lupo, Marco Alifano, Nicolas Pécuchet, et al.
Oncoimmunology|February 16, 2017
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancerLaetitia Fend, Sylvie Rusakiewicz, Julien Adam, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Oncolytic viruses and cancer therapyJonathan Pol, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Cancer Research|July 31, 2014
TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancerSaradiya Chatterjee, Lucile Crozet, Diane Damotte, et al.
Cancer Research|February 5, 2016
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable PrognosisJitka Fucikova, Etienne Becht, Kristina Iribarren, et al.
Plos One|September 20, 2014
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerMarco Alifano, Audrey Mansuet-Lupo, Filippo Lococo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophilsYoan Velut, Elise Decroix, Hélène Blons, et al.
Pageof 10